This episode of This Week in Neuroscience (TWiN) dissects a study from Cell Host & Microbe investigating the role of the gut microbiome in cerebral ischemia (stroke) recovery. The paper reveals that Lactobacillus acidophilus (LA), a common probiotic bacterium, significantly promotes cognitive function recovery and reduces neuroinflammation in a mouse model of stroke and in a small human clinical trial. The detailed mechanism elucidated involves LA enhancing the intestinal absorption of linoleic acid (LINA), an essential fatty acid. LINA then travels to the brain, specifically activating microglia in the peri-infarct region. This activation leads to a proliferation of peroxisomes within microglia, which shifts their phenotype from pro-inflammatory to anti-inflammatory. This microglial reprogramming is driven by peroxisomal beta-oxidation of fatty acids, generating acetyl-CoA which subsequently promotes histone acetylation to regulate the expression of anti-inflammatory genes, and by the elimination of reactive oxygen species (ROS). The study provides a comprehensive gut-brain axis pathway for stroke recovery, linking a dietary probiotic to epigenetic modulation in brain immune cells.
Exploring the Gut-Brain Axis: Lactobacillus Acidophilus and Stroke Recovery
0:28 The "ARC" Protein: The discussion begins with "ARC" (Activity Related Cytoskeleton Associated Protein), a retroviral capsid-like protein involved in neurotransmission, highlighted as the "Molecule of the Month" on the Protein Data Bank.
0:50 AI Limitations: An anecdote about ChatGPT incorrectly identifying an oral polio vaccine scar illustrates the current limitations and potential inaccuracies of AI tools in complex scientific and medical contexts.
1:17 Introducing the Research: The main topic is a study on Lactobacillus acidophilus (LA), a common probiotic, and its role in cognitive recovery after cerebral ischemia (stroke).
1:38 Stroke and the Gut-Brain Axis: Cerebral ischemia, a type of stroke caused by insufficient blood flow and oxygen, leads to neurological and cognitive issues. The study highlights that stroke patients often experience gastrointestinal complications (e.g., dysbiosis), which can worsen stroke outcomes via the gut-brain axis.
3:45 Human Patient Link: Initial human data showed that stroke patients with cognitive impairment had reduced levels of Lactobacillus in their gut microbiome compared to cognitively normal stroke patients.
4:20 Mouse Model Confirmation: In a mouse model of stroke (middle cerebral artery occlusion - MCAO), Lactobacillus acidophilus administration significantly improved neuroprotection, reducing infarct size, enhancing motor function and cognition, and increasing survival rates.
4:40 LA is Key: Fecal microbiota transplantation from LA-treated mice conferred similar protective effects. Conversely, using antibiotics to deplete Lactobacillus acidophilus abolished its neuroprotective benefits, confirming its direct role.
5:00 Prevention vs. Treatment: LA administration before the stroke induction was more effective than after, suggesting potential preventive benefits, particularly for chronic conditions like Moyamoya disease.
5:20 Broad Therapeutic Effects: LA treatment led to a range of improvements, including reduced weight loss, decreased neuronal apoptosis, less myelin loss, restored synapse/tight junction proteins, and alleviated blood-brain barrier disruption.
5:40 Microglial Modulation: LA treatment modulated neuroinflammation by reducing pro-inflammatory (M1-like) microglia and increasing anti-inflammatory (M2-like) microglia in the peri-infarct brain regions, alongside beneficial changes in cytokine profiles.
6:30 Behavioral Recovery: Treated mice showed improved behavioral outcomes, including accelerated motor recovery (tape removal test), reduced anxiety-like behavior, and enhanced novel object recognition.
7:00 Gut Microbiome Restoration: LA treatment also restored the disrupted gut microbiome in stroke mice towards a healthier state, increasing beneficial bacteria and reducing pathogens, while also improving intestinal barrier function.
7:40 Identifying the Mediator (Metabolomics): Metabolomic analysis of gut contents identified linoleic acid (LINA) as a crucial metabolite. Stroke decreased polyunsaturated fatty acids like LINA, and LA treatment restored these levels.
8:30 LINA Reaches the Brain: LINA levels were significantly increased in both the plasma and the peri-infarct brain tissue after LA treatment, demonstrating its transport from the gut to the brain.
9:00 LINA is Essential: Removing LINA from the diet completely abolished LA's neuroprotective effect. Intravenous LINA mimicked LA's benefits, but oral LINA did not work without LA, suggesting LA's role in LINA absorption.
10:00 Brain Pathway Modulation: RNA sequencing in brain tissue showed LA treatment downregulated inflammatory (e.g., TNF, NF-ΞΊB) and hypoxia-related (e.g., HIF-1) pathways, potentially mitigating reperfusion injury, which is secondary damage after blood flow restoration to ischemic tissue.
10:40 Peroxisome Proliferation: LA treatment significantly increased the number and activity of peroxisomes, especially in microglia, in the peri-infarct brain region. LINA was found to be crucial for this peroxisome proliferation.
11:20 Microglia and Peroxisomes are Key: Depletion of microglia or inhibition of microglial peroxisome function abolished LA's neuroprotective effects, confirming their essential role in this mechanism.
13:00 Peroxisomal Mechanisms: Peroxisomal reactive oxygen species (ROS) metabolism was linked to a pro-inflammatory microglial phenotype, while beta-oxidation of fatty acids in peroxisomes was crucial for the anti-inflammatory switch. LA treatment reduced ROS.
13:40 Epigenetic Link (Histone Acetylation): LA treatment induced histone acetylation in microglia, a process dependent on acetyl-CoA. Peroxisomal beta-oxidation of fatty acids (from LINA) generates acetyl-CoA, which then drives histone acetylation, modulating gene expression towards an anti-inflammatory microglial phenotype.
15:00 Clinical Trial Results: A small clinical trial (39 stroke patients) showed that LA treatment for three months significantly improved cognitive function and cerebral blood flow in the parietal lobe compared to a placebo group.
15:20 Human Biomarker Validation: In treated patients, brain imaging (MRA) showed new bypass vessels and increased blood flow. Fecal analysis confirmed an altered gut microbiome, increased LA, elevated long-chain fatty acids, and enriched LINA/ALA metabolic pathways.
15:50 Broader Implications: The findings suggest that LA, possibly in combination with LINA, could be a simple yet effective intervention for stroke recovery and potentially other diseases involving pro-inflammatory microglia.
16:30 Environmental Factors: The discussion touches on confounding variables like diet and cultural differences in dairy consumption, and how they might influence stroke rates globally, though such studies are complex.
1:28:57 Key Takeaway:Lactobacillus acidophilus doesn't prevent stroke, but if a stroke occurs, it can significantly aid recovery by modulating microglial function and reducing inflammation.